ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      0.00%
      US Tech 100
      19,208.00
      1.04%
      Dow Jones
      40,287.53
      0.00%
      Brent Oil
      81.20
      -1.31%
      Bitcoin
      67,852.96
      -0.45%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Astria Therapeutics Inc (ATXS) Quote

      Astria Therapeutics Inc

      Astria Therapeutics Inc (ATXS)

      NASDAQ
      11.20
      0.15
      (1.36%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      11.20
      0.00
      ( 0.00% )
      Pre Market: 8:41AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      11.20
      Bid
      10.88
      Ask
      11.54
      Volume
      23
      0.00 Day's Range 0.00
      4.26 52 Week Range 16.90
      Market Cap
      615.026M
      Previous Close
      11.20
      Open
      -
      Last Trade
      1
      @
      11.2
      Last Trade Time
      08:38:27
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      529,062
      Shares Outstanding
      54,913,061
      Dividend Yield
      -
      PE Ratio
      -6.43
      Earnings Per Share (EPS)
      -1.33
      Revenue
      -
      Net Profit
      -72.89M

      About Astria Therapeutics Inc

      Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.astriatx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Astria Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXS. The last closing price for Astria Therapeutics was $11.20. Over the last year, Astria Therapeutics shares have traded in a share price range of $ 4.26 to $ 16.90.

      Astria Therapeutics currently has 54,913,061 shares outstanding. The market capitalization of Astria Therapeutics is $615.03 million. Astria Therapeutics has a price to earnings ratio (PE ratio) of -6.43.

      ATXS Latest News

      More News

      Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...

      July 02 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 06 2024
      Edgar (US Regulatory)

      Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...

      June 04 2024
      Business Wire

      Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne...

      May 30 2024
      Business Wire

      Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present...

      May 24 2024
      Business Wire

      Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present...

      May 23 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.4-3.4482758620711.612.2510.8838718911.40311757CS
      41.7919.02231668449.4112.258.8245293210.26107503CS
      122.1223.34801762119.0812.258.5855290629.57656401CS
      263.4344.14414414417.7716.97.6981392812.17396693CS
      521.5315.82213029999.6716.94.2656978010.57807445CS
      1562.6731.30128956628.5316.92.3628704910.33458801CS
      2602.6731.30128956628.5316.92.3628704910.33458801CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MIRAMIRA Pharmaceuticals Inc
      $ 1.2701
      (84.39%)
      		18.97M
      NCPLNetcapital Inc
      $ 0.1418
      (36.35%)
      		36.24M
      SERVServe Robotics Inc
      $ 10.25
      (35.76%)
      		25.92M
      RRRichtech Robotics Inc
      $ 1.83
      (24.49%)
      		13.97M
      NUKKNukkleus Inc
      $ 0.3964
      (23.88%)
      		1.89M
      HUBCWHub Cyber Security Ltd
      $ 0.0121
      (-47.39%)
      		1.67k
      XCURExicure Inc
      $ 0.40
      (-25.25%)
      		494.41k
      SNTGSentage Holdings Inc
      $ 2.03
      (-18.15%)
      		27.59k
      PIRSPieris Pharmaceuticals Inc
      $ 6.00
      (-17.24%)
      		11
      BCBPBCB Bancorp Inc
      $ 10.20
      (-16.53%)
      		629
      NCPLNetcapital Inc
      $ 0.1418
      (36.35%)
      		36.24M
      SERVServe Robotics Inc
      $ 10.25
      (35.76%)
      		25.92M
      MIRAMIRA Pharmaceuticals Inc
      $ 1.2701
      (84.39%)
      		18.97M
      RRRichtech Robotics Inc
      $ 1.83
      (24.49%)
      		13.97M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2272
      (5.38%)
      		10.31M

      ATXS Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      ATXS under $10
      👍️0
      Monksdream Monksdream 3 months ago
      ATXS under $10
      👍️0
      GreenStockEVs GreenStockEVs 1 year ago
      NEWS OUT - Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema

      About Astria Therapeutics:

      Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Learn more about our company on our website, www.astriatx.com.
      👍️0

      Your Recent History

      NASDAQ
      ATXS
      Astria Therapeutics
      Delayed Upgrade Clock